category,datetime,headline,id,image,related,source,summary,url
company,1769186404,REGN or ILMN: Which Is the Better Value Stock Right Now?,138228580,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,REGN,Yahoo,REGN vs. ILMN: Which Stock Is the Better Value Option?,https://finnhub.io/api/news?id=69abce10d4eca528de2aa9d9065be4d5b0e95b96160d2d4041adba4a8992910e
company,1769181917,Regeneron: Q4 Earnings Preview - Why I'm Expecting A Beat And Strong 2026,138228964,,REGN,SeekingAlpha,,https://finnhub.io/api/news?id=9c2e19ee826d2b499798ff6c3275f7b38ea8efdd9f055450e24e9d3ef2659780
company,1769180405,Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,138227077,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,REGN,Yahoo,Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=13e14c05b70229377a3e27632ac8f860511dc53939e6bd72c314cb476e1e183a
company,1769163163,How Regeneron’s Broader Biologics Pipeline And Capital Return Focus At Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story,138223505,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,REGN,Yahoo,"Regeneron Pharmaceuticals has recently drawn renewed attention as investment funds, Wall Street analysts, and industry observers highlight its broad biologics pipeline, disciplined capital allocation, and avoidance of large acquisitions, alongside ongoing initiatives such as its long-term US$100 million sponsorship of the Regeneron Science Talent Search. What stands out is how investors increasingly emphasize the value of Regeneron’s pipeline beyond flagship products, viewing its focus on...",https://finnhub.io/api/news?id=1ea59578ffbbd2c76c2c237d7b7b75d6b4ccd278d71b5a0fa067b25093c29501
